New York, NY (August 1, 2014) Gabrielle’s Angel Foundation for Cancer Research is proud to announce their partnership with Keysocks, the only no-show knee high socks. Keysocks has created a special Angel Keysocks design to benefit the Foundation. The design goes on sale September 1, 2014 and runs until September 1, 2015 on www.Keysocks.com.
“We are so grateful to Shelby and the entire Keysocks team for their support of our mission,” said Denise Rich, President and Co- Founder of Gabrielle’s Angel Foundation. “I am a big fan of Keysocks and this special design for Gabrielle’s Angel Foundation serves as a fashionable reminder of our quest to cure cancer in our lifetime.”
“On behalf of our family, friends and customers who have been affected by cancer, we are incredibly excited to help spread the message of Gabrielle's Angel Foundation,” Shelby McKee, Keysocks founder, said. “Their contribution to cancer research over the years has been incredibly impactful, and we believe this partnership can further their mission of funding and awareness to find a cure for this damaging disease.”
Net proceeds from the sale of these limited-edition Angel Keysocks will directly fund the nation’s leading physician-scientists whose work represents the future of blood cancer research.
About Gabrielle’s Angel Foundation for Cancer Research
Gabrielle’s Angel Foundation funds the nation’s best and brightest scientific investigators whose research focuses on finding less toxic treatments for patients with leukemia, lymphoma, and related cancers. Since its inception, Gabrielle’s Angel Foundation has awarded $25 million in grants making it one of the largest non-governmental sources of grant support for blood cancer research in the nation. In 2012, the Foundation opened a sister chapter, Gabrielle’s Angel Foundation UK, which provides support for blood cancer research at Great Britain’s leading institutions. Help us on our quest: @CureCancerNow. For more information, please visit: gabriellesangels.org
For the official press release and press contacts, click here.